InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.11−0.04 (-3.48%)
Close on Nov 18, 2026Market cap $80.25MP/E –Yield –
InflaRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
InflaRx's shares outstanding was 68M at Jun 30, 2025. For fiscal 2025 it was 67M, up 14.2% from the year before. The highest annual figure on record is 67M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67M | +14.2% |
| FY2024 | Dec 31, 2024 | 59M | +7.2% |
| FY2023 | Dec 31, 2023 | 55M | +24.3% |
| FY2022 | Dec 31, 2022 | 44M | +6.2% |
| FY2021 | Dec 31, 2021 | 42M | +53.8% |
| FY2020 | Dec 31, 2020 | 27M | +4.1% |
| FY2019 | Dec 31, 2019 | 26M | +3.6% |
| FY2018 | Dec 31, 2018 | 25M | +166.7% |
| FY2017 | Dec 31, 2017 | 9M | +398144.8% |
| FY2016 | Dec 31, 2016 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | 68M | +53.3% |
| Q2 FY2024 | Jun 30, 2024 | 59M | +226688.1% |
| Q2 FY2023 | Jun 30, 2023 | 57M | +228850.3% |
| Q2 FY2022 | Jun 30, 2022 | 44M | – |
| Q2 FY2021 | Jun 30, 2021 | 44M | – |
| Q2 FY2019 | Jun 30, 2019 | 0M | – |
| Q2 FY2018 | Jun 30, 2018 | 0M | – |
See a number that looks wrong?